Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Enavogliflozin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech
    Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech

    09 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-unveils-innovative-drug-delivery-technologies-in-milanfrom-worlds-first-microneedle-therapy-to-once-a-month-obesity-treatment-302272175.html

    PR NEWSWIRE
    09 Oct 2024
    Share Share
    Daewoong Presents Enavogliflozin's Phase 3 Results At ADA Conference
    Daewoong Presents Enavogliflozin's Phase 3 Results At ADA Conference

    19 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-presents-enavogliflozins-phase-3-pooled-analysis-results-at-84th-ada-conference-302176658.html

    PR NEWSWIRE
    19 Jun 2024
    Share Share
    M8 and Daewoong strengthen their partnership by signing agreement for Envlo
    M8 and Daewoong strengthen their partnership by signing agreement for Envlo

    28 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/m8-pharmaceuticals-and-daewoong-pharmaceutical-strengthen-their-strategic-partnership-by-signing-an-exclusive-licensing-agreement-for-envlo-enavoglifozin-for-brazil-and-mexico-301755865.html

    PR NEWSWIRE
    28 Feb 2023
    Share Share
    Daewoong Announces Successful Phase 3 Topline Results for Enavogliflozin TCT
    Daewoong Announces Successful Phase 3 Topline Results for Enavogliflozin TCT

    25 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-announces-successful-phase-3-topline-results-for-new-antidiabetic-drugs-triple-combination-therapy-301490372.html

    PRNEWSWIRE
    25 Feb 2022
    Share Share